Produção Nacional
Revisado por pares
Effectiveness, Tolerability, and Safety of Different Amphotericin B Formulations in Invasive Fungal Infections: A Multicenter, Retrospective, Observational Study
2024; Elsevier BV; Volume: 46; Issue: 4 Linguagem: Inglês
10.1016/j.clinthera.2024.01.011
ISSN1879-114X
AutoresFrancelise Bridi Cavassin, Marcello Mihailenko Chaves Magri, J Vidal, Fabianne Carlesse, Diego R. Falci, João Luís Baú-Carneiro, Giovanni Luís Breda, Fábio de Araújo Motta, Cássia Silva de Miranda Godoy, Renata de Bastos Ascenço Soares, Carla Sakuma de Oliveira, Ana Verena Almeida Mendes, Hugo Manuel Paz Morales, Patrícia Silva Montes, Mariane Taborda, Caroline Martins Rego, Maíra Araujo Félix, Paula Pacheco Katopodis, Julia Raquel da Silva do Ó, Mirela Pereira Lima Abrão, Talita Teles Teixeira Pereira, Flávio Queiroz‐Telles,
Tópico(s)Parasitic Diseases Research and Treatment
ResumoData on the real-life use of amphotericin B lipid complex (ABLC) compared with other available formulations are limited. This study aimed to evaluate the effectiveness, tolerability, and safety of different amphotericin B (AMB) intravenously administered in the context of hospital practice for the treatment of invasive fungal infections (IFI) and to provide new insights into the profile of ABLC.
Referência(s)